Dyne Therapeutics, Inc. (DYN)
Dyne Therapeutics, Inc. (DYN) has a 23-report earnings history dating back to Nov 05, 2020. Its average absolute post-earnings move is ±4.73%, and 69.6% of those reactions were positive. Its largest post-earnings gain was +20.16% (May 08, 2025) and its largest decline was -12.89% (Nov 05, 2025). The next earnings report is predicted for 2026-07-13 (approximate).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
23
Avg Abs. Movement
±4.73%
Positive %
69.6%
Negative %
30.4%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| May 11, 2026 | ☀ PRE | $17.64 | $18.63 | $18.46 | 63,226 | +4.71% | open_in_new |
| Mar 02, 2026 | ☀ PRE | $14.78 | $16.34 | $16.15 | 2,258,000 | +3.39% | open_in_new |
| Nov 05, 2025 | ☽ POST | $21.44 | $21.45 | $20.90 | 2,368,400 | -12.89% | open_in_new |
| Jul 28, 2025 | ☽ POST | $9.97 | $9.97 | $9.31 | 2,248,500 | -1.18% | open_in_new |
| May 08, 2025 | ☀ PRE | $9.58 | $11.78 | $11.29 | 7,123,000 | +20.16% | open_in_new |
| Feb 27, 2025 | ☀ PRE | $13.70 | $14.19 | $13.17 | 2,055,600 | -4.5% | open_in_new |
| Nov 12, 2024 | ☀ PRE | $28.04 | $31.38 | $29.33 | 1,924,900 | +4.27% | open_in_new |
| Aug 12, 2024 | ☽ POST | $43.60 | $44.04 | $43.07 | 584,200 | +1.32% | open_in_new |
| May 02, 2024 | ☽ POST | $26.34 | $27.11 | $26.00 | 935,700 | +0.31% | open_in_new |
| Mar 05, 2024 | ☀ PRE | $27.66 | $28.10 | $25.87 | 1,190,100 | -6.64% | open_in_new |
| Oct 30, 2023 | ☀ PRE | $6.40 | $7.51 | $7.32 | 733,300 | +10.57% | open_in_new |
| Aug 03, 2023 | ☀ PRE | $11.57 | $11.83 | $11.50 | 291,500 | -2.21% | open_in_new |
| May 11, 2023 | ☀ PRE | $13.71 | $13.90 | $13.60 | 362,600 | -2.82% | open_in_new |
| Mar 02, 2023 | ☀ PRE | $13.73 | $14.84 | $14.32 | 445,600 | +5.06% | open_in_new |
| Nov 03, 2022 | ☀ PRE | $10.32 | $11.33 | $11.27 | 194,600 | +9.63% | open_in_new |
| Aug 04, 2022 | ☀ PRE | $10.78 | $11.59 | $11.31 | 261,400 | +3.1% | open_in_new |
| May 02, 2022 | ☽ POST | $7.97 | $8.84 | $8.52 | 200,500 | +3.52% | open_in_new |
| Mar 10, 2022 | ☀ PRE | $8.55 | $9.06 | $9.00 | 129,500 | +1.24% | open_in_new |
| Nov 04, 2021 | ☀ PRE | $14.65 | $14.85 | $14.85 | 170,000 | +0.88% | open_in_new |
| Aug 05, 2021 | ☀ PRE | $18.28 | $19.50 | $18.88 | 370,300 | +2.66% | open_in_new |
| May 06, 2021 | ☀ PRE | $17.81 | $18.36 | $18.12 | 170,300 | +1.8% | open_in_new |
| Mar 04, 2021 | ☀ PRE | $16.78 | $17.49 | $15.70 | 332,800 | -5.88% | open_in_new |
| Nov 05, 2020 | ☀ PRE | $21.26 | $22.37 | $21.29 | 344,000 | +0.14% | open_in_new |
Earnings Count
23
Total earnings in dataset
Avg Abs. Movement
±4.73%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 4 | 20260609 | open_in_new SEC.gov |
| 4 | 20260609 | open_in_new SEC.gov |
| 4 | 20260609 | open_in_new SEC.gov |
| 4 | 20260609 | open_in_new SEC.gov |
| 4 | 20260609 | open_in_new SEC.gov |
| 4 | 20260609 | open_in_new SEC.gov |
| 4 | 20260609 | open_in_new SEC.gov |
| 8-K | 20260608 | open_in_new SEC.gov |
| 4 | 20260605 | open_in_new SEC.gov |
| 8-K | 20260603 | open_in_new SEC.gov |
Frequently asked about DYN earnings
When does Dyne Therapeutics, Inc. report earnings next? expand_more
Dyne Therapeutics, Inc. (DYN)'s next earnings date is approximate for 2026-07-13. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does DYN stock move after earnings? expand_more
Over 23 reports, DYN has moved an average of ±4.73% the session after earnings, closing higher 69.6% of the time.
What was DYN's biggest post-earnings move? expand_more
DYN's largest post-earnings gain on record was +20.16% on May 08, 2025, and its largest decline was -12.89% on Nov 05, 2025.
Where can I find Dyne Therapeutics, Inc.'s SEC filings? expand_more
All of Dyne Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right